News

Renata Block, MMS, PA-C, and Michael Rubio, PA-C discuss the complexities of developing a telehealth program in the world of dermatology.

Explore 2025’s dermatology M&A trends, economic shifts, and key investment drivers shaping the industry's future.

The state-of-the-art facilities in California, Georgia, and Texas will expand AMI’s curriculum to providers of all levels.

Barbieri et al evaluated product use, benzoyl peroxide concentration, days until expiration, and more.

Are you attending Winter Clinical Hawaii? Answer our poll below to let us know.

Alexandra Golant, MD, led a Dermatology Times Case-Based Roundtable® event that focused on advancing therapeutic strategies for atopic dermatitis.

Hawkes discusses urticaria subtypes, treatments, and emerging therapies like dupilumab and remibrutinib.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Clinicians observed a positive relationship between scalp hair regrowth and downstream treatment benefits for patients with alopecia areata.

Uniting all professions should be the goal as it concerns the patient and the access to care.

Catch up on coverage from the 2025 Masters of Pediatric Dermatology held in Miami Beach, Florida.

Trauma-induced melanocyte implantation can lead to subcutaneous melanoma, mimicking melanoma of unknown primary but with distinct diagnostic criteria.

At the Horizons in Advanced Practice meeting, Douglas DiRuggiero, DMSc, MHS, PA-C, presented a case of a woman aged 27 years who had eczematous lesions covering more than 20% of her BSA.

New drugs targeting IL-4, IL-13, and IL-31 pathways provide options for tailored eczema treatments.

Each treatment saw very mild clinical and dermatologic responses with low levels of patient satisfaction.

This review of the latest dermatologic studies includes insights into endocrine, psychological and nutritional aspects in women with hidradenitis suppurativa; forms of hair loss among individuals with anxiety disorder; and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Lisa Weiss, MMSc, PA-C, and colleagues offered insights on managing severe atopic dermatitis cases with biologics, nonsteroidal treatments, and strategies for addressing physical and emotional impacts.

Catch up on coverage from the 2025 South Beach Symposium held in Miami Beach, Florida.

Recent technological advancements such as the development and use of human cellular and tissue-based products and advanced skin substitutes have transformed limb preservation.

Dobkin underwent the procedure in order to connect with his patients considering it for themselves.

Botox Cosmetic has evolved from its accidental discovery to a leading treatment in dermatology, balancing medical innovation with ethical considerations.

A recent expert discussion highlighted the importance of long-term planning, including when and how to adjust or transition therapies.

The top videos under the hashtag, #spironolactone” had low scores on the mDISCERN and GQS scales, according to Adam Friedman, MD, FAAD, senior author of the study.

Review emerging therapies for vitiligo, melasma, PIH, and albinism, including topical, systemic, light-based, and laser treatments.

Tina Bhutani-Jacques, MD, highlighted the importance of individualized and informative care while building trust among patients and caregivers.

Explore the top headlines of the week including Allergan Aesthetics' new AA Signature program, the launch of EltaMD's new UV Skin Recovery broad spectrum SPF 50 face sunscreens, and more.

Lio emphasizes that patient comfort and understanding are essential for successful treatment outcomes.

Nektar Therapeutics’ investigational biologic targets the IL-2 receptor complex.

Many patients, especially parents of pediatric patients, exhibit steroid phobia, impacting treatment adherence.